ARCHIVES

Columbia Next for comprehensive Center Review

This article is from The Cancer Letter archive.

Vol. 03 No. 07 | February 18, 1977

Download PDF Visit The Full Archive

Related Articles

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

IOM Report Urges DOD, VA, Congress To End Tobacco Use In Military.

July 10, 2009

Supplements Reduce Deaths In NCI Studies In China “JNCI”

September 17, 1993